Keyphrases
30-day Mortality
28%
Adult Patients
13%
All-cause Mortality
11%
Antibiotic Duration
13%
Antibiotic Therapy
16%
Antibiotic Treatment
14%
Antibiotics
22%
Bacteremia
35%
C. Difficile Toxin
10%
Candida
11%
Clinical Characteristics
14%
Clinical Features
12%
Clinical Outcomes
39%
Clostridioides Difficile
19%
Clostridium Difficile Infection
52%
Clostridium Difficile-associated Diarrhea
21%
Confidence Interval
43%
COVID-19
13%
Diarrhea
11%
Difficile
11%
Epidemiology
13%
Gram-negative Bacteremia
14%
Hospitalization
13%
Hospitalized Patients
38%
Infective Endocarditis
31%
Influenza
12%
Invasive Pneumococcal Disease
15%
Israel
92%
Klebsiella Pneumoniae (K. pneumoniae)
11%
Klebsiella Pneumoniae Carbapenemase
17%
Long-term Mortality
12%
Lung Transplantation
16%
Methicillin-resistant Staphylococcus Aureus
19%
Mortality Rate
11%
Multivariate Analysis
17%
Mycobacterium Simiae
11%
Obesity
11%
Odds Ratio
32%
Pneumonia
14%
Polymerase Chain Reaction
15%
Randomized Controlled Trial
15%
Retrospective Cohort Study
23%
Risk Factors
33%
Single Center
15%
Staphylococcus Aureus
11%
Staphylococcus Aureus Bacteremia
35%
Statins
12%
Tertiary Care Hospital
24%
Trimethoprim-sulfamethoxazole (TMP-SMX)
12%
Vancomycin
26%
Pharmacology, Toxicology and Pharmaceutical Science
All Cause Mortality
18%
Antibiotic Agent
12%
Antibiotic Associated Diarrhea
8%
Antibiotic Therapy
16%
Antibiotics
49%
Antiinfective Agent
10%
Bacteremia
40%
Bacterial Endocarditis
7%
Bloodstream Infection
9%
Candida
8%
Candidemia
9%
Carbapenem
14%
Carbapenem Resistant Enterobacteriaceae
7%
Case-Control Study
9%
Clostridium Difficile Infection
47%
Cohort Study
27%
Comorbidity
11%
Cotrimoxazole
13%
Diabetes Mellitus
10%
Diarrhea
11%
Disease
21%
Endocarditis
10%
Extended Spectrum Beta Lactamase
10%
Fluconazole
13%
Gram Negative Bacterium
12%
Gram Negative Sepsis
17%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
11%
Immunocompromised Patient
7%
Infection
91%
Infectious Agent
16%
Klebsiella pneumoniae
12%
Malignant Neoplasm
8%
Methicillin Resistant Staphylococcus Aureus Infection
13%
Methicillin-Resistant Staphylococcus Aureus
14%
Mortality Rate
14%
Multiple Myeloma
7%
Observational Study
13%
Peptoclostridium difficile
16%
Pneumococcal Infection
15%
Randomized Controlled Trial
27%
Retrospective Study
28%
SARS Coronavirus
7%
Seasonal Influenza
9%
Soft Tissue Infection
7%
Staphylococcal Bacteremia
27%
Staphylococcus Aureus
16%
Statin (Protein)
8%
Thrombocytopenia
7%
Urinary Tract Infection
9%
Vancomycin
16%
Medicine and Dentistry
All Cause Mortality
12%
Antibiotic Therapy
31%
Antibiotic-Associated Diarrhea
8%
Antibiotics
29%
Antiinfective Agent
7%
Bacteremia
21%
Bloodstream Infection
9%
Cancer
8%
Candidemia
8%
Carbapenem
11%
Clostridium Difficile Infection
41%
Cohort Analysis
8%
Diabetes Mellitus
8%
Diarrhea
16%
Disease
13%
Emergency Department
8%
External Otitis
7%
Fluconazole
10%
Gram Negative Sepsis
11%
Gram-Negative Bacteria
11%
Hemodialysis
8%
Immunoaffinity Chromatography
7%
Infection
100%
Infective Endocarditis
23%
Influenza A
10%
Intensive Care Unit
15%
Internal Medicine
8%
Klebsiella pneumoniae
10%
Lung Transplantation
16%
Methicillin Resistant Staphylococcus Aureus
7%
Mortality Rate
15%
Multiple Myeloma
7%
Multivariate Analysis
11%
Mycobacterium simiae
7%
Nocardiosis
7%
Odds Ratio
17%
Pathogen
22%
Peptoclostridium difficile
19%
Pericarditis
7%
Pneumococcal Infection
11%
Polymerase Chain Reaction
17%
Randomized Controlled Trial
12%
Recurrence Risk
8%
Retrospective Cohort Study
13%
Retrospective Study
36%
Seasonal Influenza
8%
Staphylococcal Bacteremia
12%
Staphylococcus Aureus
9%
Triggering Receptor Expressed on Myeloid Cells 1
7%
Urinary Tract Infection
8%